Company
OS Therapies Inc (OSTX)
Standardized SEC financial data for OS Therapies Inc — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001795091 · NYSE · Pharmaceutical Preparations.
Return on equity
471.7%
Free cash flow
-$14.7M
Current ratio
0.03×
EPS (diluted)
$-0.98
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $3.2M | $2.8M | $16.4M |
| SG&A expense | $1.1M | $4.0M | $12.3M |
| Operating income | -$4.3M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $171K | $39K | $5.5M | $270K |
| Total current assets | — | $790K | $5.5M | $333K |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$3.0M | -$7.3M | -$14.2M |
| Capital expenditures | — | — | $466K |
| Free cash flow | — | — |
Get OSTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OSTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OSTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"